misleading statements

The Gross Law Firm launched a shareholder class action against BellRing Brands (BRBR), alleging misleading statements about sales growth and competitive pressures from November 2024 to August 2025.

Ramaco Resources faces class action over allegedly misleading statements about Brook Mine operations. Lead plaintiff deadline set for March 31, 2026.

Gemini Space Station Inc. ($GEMI) sued for securities violations over allegedly false IPO statements regarding crypto platform viability and international expansion plans.

UniQure faces securities fraud lawsuit alleging false FDA approval and BLA timeline claims. Investors in stock between September-October 2025 can join class action by April 2026 deadline.

uniQure faces class action lawsuit alleging misleading statements about pivotal study design and FDA approval prospects. Shareholders have until April 13, 2026 to join.

Apollo Global Management ($APO) stock plunged 15% after revelations of undisclosed business dealings with Jeffrey Epstein, triggering a securities class action lawsuit against CEO Marc Rowan.

Schall Law Firm files class action against Gemini Space Station Inc. ($GEMI) alleging false statements about crypto platform viability and overstated expansion prospects.

Hagens Berman investigates $QURE for misrepresenting FDA interactions on gene therapy AMT-130. Stock crashed 49% after FDA publicly rebuked company's data claims.

Corcept Therapeutics faces class action lawsuit for allegedly misrepresenting FDA trial data; stock collapsed 50% after regulatory rejection of relacorilant drug.

PayPal faces securities lawsuit after CEO ousted, 2027 targets withdrawn. Stock plunged 20%, erasing $10B market cap amid allegations of investor misleading.

The Schall Law Firm investigates Neumora Therapeutics ($NMRA) for potential securities fraud involving false statements or material information omissions.

$ODD stock crashes 49% after revealing 30% Q1 revenue decline tied to advertising partner algorithm shift. Securities lawsuit filed over disclosure failures.

Class actions filed against $PYPL over false revenue projections and $RGENX after FDA clinical hold on gene therapy following safety concerns.

China Liberal Education Holdings faces class action securities fraud lawsuit alleging pump-and-dump scheme and failure to disclose material information during January 2025.

Class action lawsuit filed against Inovio Pharmaceuticals ($INO) for allegedly making false statements about INO-3107 treatment and manufacturing capabilities, causing significant stock declines.

Class action lawsuit filed against $ALIT alleging executives made false statements about growth and cost cuts while concealing sales execution failures.

Class action lawsuit filed against $ALIT over alleged false statements on growth and cost-cutting. Stock fell 18.3% in August 2025, 38.2% in February 2026 following earnings misses.

Class action lawsuit filed against REGENXBIO alleging false statements about RGX-111 gene therapy development and clinical trials, covering investors from February 2022 through January 2026.

Class action lawsuit filed against $UQRR alleging materially false statements about FDA approval and BLA timeline delays. Investors urged to join by April 13, 2026 deadline.

Portnoy Law Firm files class action against Camping World Holdings ($CWH) for allegedly making false statements about inventory management and consumer demand between April 2025 and February 2026.